IUBMB Life

Papers
(The H4-Index of IUBMB Life is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information85
Issue Information49
Serum/glucocorticoid‐regulated kinase 1‐targeted transient receptor potential oxalate subtype 1 regulates bladder smooth muscle cell proliferation due to bladder outlet obstruction in mice via activat45
Protein Tyrosine Phosphatases: Mighty oaks from little acorns grow45
Irisin alleviates the pyroptosis of β cells in T2DM by inhibiting NLRP3 inflammasome through regulating miR‐19b‐3p/SOCS3/STAT3 axis mediated auto42
Anti‐inflammatory effects of sodium‐glucose cotransporter‐2 inhibitors in COVID‐1941
Mitochondrial protein and organelle quality control—Lessons from budding yeast40
The role of the proteasome in mitochondrial protein quality control39
The roles of proteases in prostate cancer38
36
SHP2: The protein tyrosine phosphatase involved in chronic pulmonary inflammation and fibrosis32
Modulation of PPAR‐α and PPAR‐γ Influences Cardiomyocyte Growth and Cardiac Remodeling29
Integrated multi‐omics and machine learning reveal a gefitinib resistance signature for prognosis and treatment response in lung adenocarcinoma28
Discovery and Validation of a New Biomarker Integrating Ferroptosis and Glycolysis‐Related Genes in Bladder Cancer27
Issue Information24
Central nervous system cholesterol metabolism in health and disease24
Thiourea derivatives inhibit key diabetes‐associated enzymes and advanced glycation end‐product formation as a treatment for diabetes mellitus23
SNHG14 promotes triple‐negative breast cancer cell proliferation, invasion, and chemoresistance by regulating the ERK/MAPK signaling pathway23
22
Issue Information22
Preface to IUBMB life special issue on protein phosphorylation dedicated to Eddy Fischer21
Potential COVID‐19 remedies from repurposed drugs and herbal small RNAs21
Combined doxorubicin and arctigenin treatment induce cell cycle arrest‐associated cell death by promoting doxorubicin uptake in doxorubicin‐resistant breast cancer cells21
0.065038919448853